Nanocarriers in Prostate Cancer

Dr. Bhupendra Gopalbhai Prajapati is Professor (Research Cadre) at Parul Institute of Pharmacy, Parul University, Gujarat, India, and serves as Adjunct Professor in the Department of Industrial Pharmacy at Silpakorn University, Thailand. His academic, research, and industry expertise focuses on lipid‑based formulations, nano‑ and microparticulate drug delivery systems, and strategies to enhance drug bioavailability. Dr. Prajapati has received several academic and professional honors recognizing excellence in teaching and research. He has made substantial scholarly contributions through research and review publications, book chapters, and edited volumes in pharmaceutical sciences. Actively engaged in postgraduate and doctoral mentoring, he supports research training in advanced drug delivery and formulation science. Dr. Prajapati also serves in editorial and section‑editor roles for international scientific publications, contributing to the advancement and quality of pharmaceutical research dissemination. Dr. Devesh U. Kapoor is Professor of Pharmaceutics at Dr. Dayaram Patel Pharmacy College, Bardoli, Gujarat, affiliated with Gujarat Technological University. His academic and research expertise centers on pharmaceutics, nanodrug delivery, and modified‑release drug delivery systems. Dr. Kapoor has made extensive scholarly contributions through research and review publications, book chapters, and edited volumes with international publishers. He is actively involved in postgraduate and doctoral research supervision in advanced drug delivery technologies. His editorial experience includes serving in senior editorial roles for international journals across pharmacology, pharmaceutics, and biomedical sciences, along with regular peer‑review activity for a wide range of scientific journals. Dr. Kapoor has also secured competitive research and academic development funding and is a frequent invited speaker at national scientific meetings, workshops, and academic programs. Currently working as an Assistant Professor in the Department of Pharmacology and Toxicology at College of Pharmacy King Saud University, Riyadh Saudi Arabia. Before joining King Saud University worked as a Post-Doctoral Scholar in the School of Medicine, University of Kentucky, Lexington, USA.. Currently involved in teaching, research, and research is mainly focused on finding the molecular mechanisms involved in cancer chemoprevention and chemotherapy-induced vital organ toxicity and their prevention using natural and synthetic compounds using in-vivo and in-vitro models. He has published more than 130 research, review and book chapters in highly reputed international journals.Anand Krishnan is Principal Investigator in Chemical Pathology at the Faculty of Health Sciences, University of the Free State, South Africa, where he leads the Precision Medicine Integrative Nano Diagnostics (P-MIND) laboratories. His research focuses on the biological functions of extracellular vesicles in synthetic biology, including cell surface protein modification, biomarker discovery using liquid biopsy-derived extracellular vesicles, and the role of circulating biomarkers in disease development and stem cell biology. He leads multidisciplinary research in precision medicine and nanoscale diagnostics, with a particular interest in translational applications of extracellular vesicle science. Krishnan is an active member of the International Society for Extracellular Vesicles, the African Organisation for Research and Training in Cancer, and the American Association for Cancer Research. He has also served in editorial roles supporting scientific research and publishing.

• 1. Introduction2. Polymeric Nanoparticles: Advancing Prostate Cancer Treatment3. Advances in silica-based nanoparticles for targeting prostate cancer4. Breakthrough in magnetic nanoparticles for management of prostate cancer5. Innovative approaches of metallic (gold, silver) nanoparticles in targeting of prostate cancer6. Recent application of liposomes, niosomes and exosomes in precise targeting of prostate cancer7. Therapeutic Potential of Dendrimers in Prostate Cancer: Advances and Challenges8. Carbon Nanotubes in Prostate Cancer: Emerging Frontiers in Diagnosis and Therapy9. Targeted therapy of quantum dots against prostate cancer10. Nanoemulsions and Nanosuspensions: Innovative Nanocarrier Systems for Prostate Cancer Management11. Nanogels in Prostate Cancer: A Novel Avenue for Targeted Therapy and Enhanced Drug Delivery12. DNA Origami Nanocarriers: Revolutionizing Prostate Cancer Therapy

Select Guide Rating